160 related articles for article (PubMed ID: 31138783)
1. Cloxiquine, a traditional antituberculosis agent, suppresses the growth and metastasis of melanoma cells through activation of PPARγ.
Zhang W; Shao W; Dong Z; Zhang S; Liu C; Chen S
Cell Death Dis; 2019 May; 10(6):404. PubMed ID: 31138783
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activating receptors: a new way to treat melanoma?
Schadendorf D
J Invest Dermatol; 2009 May; 129(5):1061-3. PubMed ID: 19369932
[TBL] [Abstract][Full Text] [Related]
3. Identification of an irreversible PPARγ antagonist with potent anticancer activity.
Peng Y; Zhang Q; Zielinski RM; Howells RD; Welsh WJ
Pharmacol Res Perspect; 2020 Dec; 8(6):e00693. PubMed ID: 33280279
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo anti-melanoma effects of ciglitazone.
Botton T; Puissant A; Bahadoran P; Annicotte JS; Fajas L; Ortonne JP; Gozzerino G; Zamoum T; Tartare-Deckert S; Bertolotto C; Ballotti R; Rocchi S
J Invest Dermatol; 2009 May; 129(5):1208-18. PubMed ID: 19177142
[TBL] [Abstract][Full Text] [Related]
5. The α-melanocyte stimulating hormone/peroxisome proliferator activated receptor-γ pathway down-regulates proliferation in melanoma cell lines.
Flori E; Rosati E; Cardinali G; Kovacs D; Bellei B; Picardo M; Maresca V
J Exp Clin Cancer Res; 2017 Oct; 36(1):142. PubMed ID: 29020973
[TBL] [Abstract][Full Text] [Related]
6. Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells.
Koch A; Lang SA; Wild PJ; Gantner S; Mahli A; Spanier G; Berneburg M; Müller M; Bosserhoff AK; Hellerbrand C
Oncotarget; 2015 Oct; 6(32):32748-60. PubMed ID: 26293674
[TBL] [Abstract][Full Text] [Related]
7. Automated in vivo screen in zebrafish identifies Clotrimazole as targeting a metabolic vulnerability in a melanoma model.
Precazzini F; Pancher M; Gatto P; Tushe A; Adami V; Anelli V; Mione MC
Dev Biol; 2020 Jan; 457(2):215-225. PubMed ID: 30998907
[TBL] [Abstract][Full Text] [Related]
8. Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARγ.
Han M; Gao H; Ju P; Gao MQ; Yuan YP; Chen XH; Liu KL; Han YT; Han ZW
Biomed Pharmacother; 2018 Jul; 103():272-283. PubMed ID: 29656183
[TBL] [Abstract][Full Text] [Related]
9. Critical role of PPARγ in myeloid-derived suppressor cell-stimulated cancer cell proliferation and metastasis.
Zhao T; Du H; Blum JS; Yan C
Oncotarget; 2016 Jan; 7(2):1529-43. PubMed ID: 26625314
[TBL] [Abstract][Full Text] [Related]
10. PPAR γ agonist, pioglitazone, suppresses melanoma cancer in mice by inhibiting TLR4 signaling.
Dana N; Vaseghi G; Haghjooy Javanmard S
J Pharm Pharm Sci; 2019; 22(1):418-423. PubMed ID: 31509504
[TBL] [Abstract][Full Text] [Related]
11. Identification of a small molecule that downregulates MITF expression and mediates antimelanoma activity in vitro.
Cheng C; Yang HW; Shang JF; Li WW; Sun QZ; Chen X; Cao ZX; Yao SH; Yang SY
Melanoma Res; 2016 Apr; 26(2):117-24. PubMed ID: 26684062
[TBL] [Abstract][Full Text] [Related]
12. Anti-proliferative effect of peroxisome proliferator-activated receptor gamma agonists on human malignant melanoma cells in vitro.
Freudlsperger C; Moll I; Schumacher U; Thies A
Anticancer Drugs; 2006 Mar; 17(3):325-32. PubMed ID: 16520661
[TBL] [Abstract][Full Text] [Related]
13. Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma during malignant melanoma progression.
Lee C; Ramirez JA; Guitart J; Diaz LK
J Cutan Pathol; 2008 Nov; 35(11):989-94. PubMed ID: 18537861
[TBL] [Abstract][Full Text] [Related]
14. N-acylsphingosine amidohydrolase 1 promotes melanoma growth and metastasis by suppressing peroxisome biogenesis-induced ROS production.
Malvi P; Janostiak R; Nagarajan A; Zhang X; Wajapeyee N
Mol Metab; 2021 Jun; 48():101217. PubMed ID: 33766731
[TBL] [Abstract][Full Text] [Related]
15. Activation of PPARγ and inhibition of cell proliferation reduces key proteins associated with the basal subtype of bladder cancer in As3+-transformed UROtsa cells.
Mehus AA; Bergum N; Knutson P; Shrestha S; Zhou XD; Garrett SH; Sens DA; Sens MA; Somji S
PLoS One; 2020; 15(8):e0237976. PubMed ID: 32822399
[TBL] [Abstract][Full Text] [Related]
16. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma.
He BC; Chen L; Zuo GW; Zhang W; Bi Y; Huang J; Wang Y; Jiang W; Luo Q; Shi Q; Zhang BQ; Liu B; Lei X; Luo J; Luo X; Wagner ER; Kim SH; He CJ; Hu Y; Shen J; Zhou Q; Rastegar F; Deng ZL; Luu HH; He TC; Haydon RC
Clin Cancer Res; 2010 Apr; 16(8):2235-45. PubMed ID: 20371684
[TBL] [Abstract][Full Text] [Related]
17. Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growth.
Gowda R; Sharma A; Robertson GP
Cancer Lett; 2017 Jan; 385():243-250. PubMed ID: 27769779
[TBL] [Abstract][Full Text] [Related]
18. Azidothymidine inhibits melanoma cell growth in vitro and in vivo.
Humer J; Ferko B; Waltenberger A; Rapberger R; Pehamberger H; Muster T
Melanoma Res; 2008 Oct; 18(5):314-21. PubMed ID: 18781129
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt.
Grabacka M; Plonka PM; Urbanska K; Reiss K
Clin Cancer Res; 2006 May; 12(10):3028-36. PubMed ID: 16707598
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal Zn
Du W; Gu M; Hu M; Pinchi P; Chen W; Ryan M; Nold T; Bannaga A; Xu H
Cell Rep; 2021 Oct; 37(3):109848. PubMed ID: 34686351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
